Afimmune Competitors and Similar CompaniesClear all
Afimmune's competitors and similar companies include Amarin and Biogen.
 Amarin Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases. |  Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | ||
Founding Date | Founding Date N/A | Founding Date 1991 | Founding Date 1978 |
Type | Type Private | Type Public | Type Public |
Tags | |||
Locations | Locations Dublin, IE HQ | Locations Dublin, IE HQ Zug, CH Bridgewater Township, US | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 13 | Employees 275 | Employees 7,605 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 257.6 m | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $213.6m (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $120.9m (FY, 2025) | Gross profit $7.5b (FY, 2025) |
Net income | Net income N/A | Net income ($38.8m) (FY, 2025) | Net income $1.3b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Amarin
HQ
Dublin, IE
Employees
275
Amarin Corporation is a pharmaceutical company that engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases.
View companyBiogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company